Compound information
- Natural Products
- NACP62354
- Molecular Formula
- C14H19NO4
- Molecular Weight
- 265.131408088 g/mol
- Structure
-
- IUPAC Name
- 2-(benzyloxycarbonylamino)-3-methyl-pentanoic acid
- InChI
- InChI=1S/C14H19NO4/c1-3-10(2)12(13(16)17)15-14(18)19-9-11-7-5-4-6-8-11/h4-8,10,12H,3,9H2,1-2H3,(H,15,18)(H,16,17)
- InChI Key
- JSHXJPFZKBRLFU-UHFFFAOYSA-N
- SMILES
- O=C(OCC=1C=CC=CC1)NC(C(=O)O)C(C)CC
- CAS
- 55723-45-0
- SuperClass
- Organic acids and derivatives
- Class
- Carboxylic acids and derivatives
- SubClass
- Amino acids, peptides, and analogues
- Source
- CNP0054856
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 19 | Ring Count | 1 |
Heteroatom Count | 5 | Rotatable Bond Count | 6 |
Hydrogen Bond Acceptor Count | 3 | Hydrogen Bond Donor Count | 2 |
Topological Polar Surface Area | 75.63 Å2 | LogP | 2.454 |
LogS | -3.08 | LogD | 1.921 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.042 | Pgp substrate | 0.002 |
HIA | 0.962 | F20 % | 0.991 |
F30 % | 0.936 | Caco-2 | -5.162 |
MDCK | -4.553 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.94 | PPB | 64.653 |
VD | 0.224 | Fu | 0.64 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.002 | CYP1A2 substrate | 0.562 |
CYP2A6 substrate | 0.425 | CYP2B6 substrate | 0.482 |
CYP2C19 inhibitor | 0.03 | CYP2C19 substrate | 0.484 |
CYP2C8 substrate | 0.611 | CYP2C9 inhibitor | 0.036 |
CYP2C9 substrate | 0.044 | CYP2D6 inhibitor | 0.017 |
CYP2D6 substrate | 0.171 | CYP2E1 substrate | 0.267 |
CYP3A4 inhibitor | 0.01 | CYP3A4 substrate | 0.085 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.865 | CL | 1.666 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.001 | Hepatotoxicity | 0.457 |
Mutagenicity | 0.004 | Rat Oral Acute Toxicity | 0.017 |
FDAMDD | 0.031 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.005 | Eye Corrosion | 0.002 |
Eye Irritation | 0.006 | Respiratory Toxicity | 0.004 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.12 | IGC50 | 2.562 |
LC50FM | 3.788 | LC50DM | 4.313 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.185 | NR-AR-LBD | 0.226 |
NR-AhR | 0.003 | NR-Aromatase | 0.048 |
NR-ER | 0.238 | NR-ER-LBD | 0.336 |
NR-PPAR-gamma | 0.397 | SR-ARE | 0.027 |
SR-ATAD5 | 0.347 | SR-HSE | 0.092 |
SR-MMP | 0.011 | SR-p53 | 0.017 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.